<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Decoy receptor 3 (DcR3), a member of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor receptor superfamily, has been implicated in <z:mp ids='MP_0002006'>tumorigenesis</z:mp> through its abilities to modulate immune responses and induce <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Epstein-Barr virus (EBV), a ubiquitous gamma-herpesvirus, is associated with <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> including nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> (NPC) </plain></SENT>
<SENT sid="2" pm="."><plain>Previous studies show that DcR3 is overexpressed in EBV-positive <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and Rta, an EBV transcription activator, can upregulate DcR3 in Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines </plain></SENT>
<SENT sid="3" pm="."><plain>However, DcR3 expression has not been demonstrated in EBV-associated NPC nor have there been any EBV latent genes linked to DcR3 upregulation </plain></SENT>
<SENT sid="4" pm="."><plain>Here, we showed DcR3 was overexpressed in NPC </plain></SENT>
<SENT sid="5" pm="."><plain>Higher DcR3 expression score and DcR3-positive rate were found in metastatic NPC than in primary NPC tissues, suggesting DcR3 may enhance cell metastatic potential </plain></SENT>
<SENT sid="6" pm="."><plain>This hypothesis is supported by our observation that NPC HONE-1 cells overexpressing DcR3 exhibited significant higher migration and invasion abilities in vitro </plain></SENT>
<SENT sid="7" pm="."><plain>We found besides Rta, EBV latent membrane protein (LMP) 1 can upregulate DcR3 via nuclear factor-kappaB and phosphatidylinositol 3-kinase-signaling events </plain></SENT>
<SENT sid="8" pm="."><plain>Approximate 75% of LMP1-positive NPC tissues overexpressed DcR3, suggesting LMP1 may enhance DcR3 expression in vivo </plain></SENT>
<SENT sid="9" pm="."><plain>Data herein suggested that increasing DcR3 expression by LMP1 not only helps EBV-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells gain survival advantage by preventing host immune detection but also increases the chance of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> by enhancing cell migration and invasion </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these DcR3-mediated events facilitate <z:mpath ids='MPATH_458'>normal</z:mpath> cells to gain <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> hallmarks </plain></SENT>
</text></document>